德尔福斯平台:一种基于模型的概念解决方案,用于提升精密医学
概括
精准医学的基因组数据集成面临着挑战. 德尔福斯平台使用SILE方法和概念性基因组图表来解决这些问题,用于临床应用.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 精准医学是一门精准的医学.
背景情况:
- 基因组数据的临床应用受到数据分散,异质性和质量问题的阻碍.
- 这些挑战阻碍了精准医学 (PM) 的进步.
研究的目的:
- 介绍Delfos平台,该平台旨在缓解将基因组研究转移到临床实践中的问题.
- 引入SILE方法和支持Delfos平台的基因组概念图.
主要方法:
- 基于概念模型,严格的方法和本体学的Delfos平台的开发.
- 实施SILE方法的方法支持.
- 创建一个概念的基因组图的领域理解.
- 描述平台的技术架构.
主要成果:
- 德尔福斯平台提供了一个结构化的方法来管理基因组数据挑战.
- 两个用例证明了该平台在研究扩展性心肌病和神经母细胞瘤风险的DNA变异中的实用性.
结论:
- 德尔福斯平台有效地减少了基因组数据问题在临床实践中的影响.
- 这种方法有助于将基因组研究成果转化为精准医学的可操作的临床见解.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...


